NATURE’S SUNSHINE PRODUCTS, INC. Capital Expenditures
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Capital Expenditures of $5.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.78M, a 105.63% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.48M, a 123.42% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.34M, a 6.47% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.68M, a 3.05% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $6.48M, a 40.94% decline from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $10.97M, a 4.71% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $10.48M, a 37.36% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $7.63M, a 14.43% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.26M 10-Q · filed 2026-08-06 | $7.59M derived: sum of 3 quarters · filed 2026-08-06 | $9.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.48M 10-Q · filed 2026-05-07 | $4.82M derived: sum of 2 quarters · filed 2026-05-07 | $6.50M derived: sum of 3 quarters · filed 2026-05-07 | $7.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.02M derived: sum of 2 quarters · filed 2026-03-10 | $5.37M derived: sum of 3 quarters · filed 2026-08-06 | $6.48M 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.03M derived: sum of 2 quarters · filed 2026-08-06 | $4.14M 10-Q · filed 2025-11-06 | $6.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.46M 10-Q · filed 2026-08-06 | $4.66M derived: sum of 3 quarters · filed 2026-08-06 | $6.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-07 | $3.31M derived: sum of 2 quarters · filed 2026-05-07 | $5.04M derived: sum of 3 quarters · filed 2026-05-07 | $8.39M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.93M derived: sum of 2 quarters · filed 2026-03-10 | $7.28M derived: sum of 3 quarters · filed 2026-03-10 | $10.97M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.09M derived: sum of 2 quarters · filed 2025-11-06 | $8.78M 10-Q · filed 2025-11-06 | $10.02M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $7.04M 10-Q · filed 2025-07-31 | $8.29M derived: sum of 3 quarters · filed 2025-07-31 | $12.77M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $3.69M 10-Q · filed 2025-05-06 | $4.94M derived: sum of 2 quarters · filed 2025-05-06 | $9.42M derived: sum of 3 quarters · filed 2025-05-06 | $11.84M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.73M derived: sum of 2 quarters · filed 2025-03-11 | $8.15M derived: sum of 3 quarters · filed 2025-03-11 | $10.48M 10-K · filed 2025-03-11 |
| 2023-09-30 | $4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.91M derived: sum of 2 quarters · filed 2024-11-07 | $9.23M 10-Q · filed 2024-11-07 | $12.13M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.75M 10-Q · filed 2024-08-08 | $7.64M derived: sum of 3 quarters · filed 2024-08-08 | $8.62M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $2.33M 10-Q · filed 2024-05-07 | $5.22M derived: sum of 2 quarters · filed 2024-05-07 | $6.20M derived: sum of 3 quarters · filed 2024-05-07 | $8.44M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $3.87M derived: sum of 2 quarters · filed 2024-03-12 | $6.11M derived: sum of 3 quarters · filed 2024-03-12 | $7.63M 10-K · filed 2024-03-12 |
| 2022-09-30 | $973.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.21M derived: sum of 2 quarters · filed 2023-11-07 | $4.73M 10-Q · filed 2023-11-07 | $6.77M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.76M 10-Q · filed 2023-08-09 | $5.80M derived: sum of 3 quarters · filed 2023-08-09 | $7.53M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.52M 10-Q · filed 2023-05-09 | $3.56M derived: sum of 2 quarters · filed 2023-05-09 | $5.29M derived: sum of 3 quarters · filed 2023-05-09 | $7.20M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.77M derived: sum of 2 quarters · filed 2023-03-16 | $5.68M derived: sum of 3 quarters · filed 2023-03-16 | $6.67M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.64M derived: sum of 2 quarters · filed 2022-11-03 | $4.63M 10-Q · filed 2022-11-03 | $6.04M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.90M 10-Q · filed 2022-08-09 | $4.32M derived: sum of 3 quarters · filed 2022-08-09 | $5.59M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $983.00K 10-Q · filed 2022-05-05 | $2.40M derived: sum of 2 quarters · filed 2022-05-05 | $3.68M derived: sum of 3 quarters · filed 2022-05-05 | $4.68M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $2.69M derived: sum of 2 quarters · filed 2022-03-08 | $3.70M derived: sum of 3 quarters · filed 2022-03-08 | $4.91M 10-K · filed 2022-03-08 |
| 2020-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.28M derived: sum of 2 quarters · filed 2021-11-04 | $3.49M 10-Q · filed 2021-11-04 | $4.12M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.21M 10-Q · filed 2021-08-05 | $2.84M derived: sum of 3 quarters · filed 2021-08-05 | $4.54M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.21M 10-Q · filed 2021-05-06 | $1.84M derived: sum of 2 quarters · filed 2021-05-06 | $3.54M derived: sum of 3 quarters · filed 2021-05-06 | $5.93M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $2.33M derived: sum of 2 quarters · filed 2021-03-10 | $4.72M derived: sum of 3 quarters · filed 2021-03-10 | $5.10M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.09M derived: sum of 2 quarters · filed 2020-11-09 | $4.47M 10-Q · filed 2020-11-09 | $5.35M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.77M 10-Q · filed 2020-08-06 | $3.65M derived: sum of 3 quarters · filed 2020-08-06 | $4.94M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $387.00K 10-Q · filed 2020-05-11 | $1.26M derived: sum of 2 quarters · filed 2020-05-11 | $2.55M derived: sum of 3 quarters · filed 2020-05-11 | $4.73M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $2.16M derived: sum of 2 quarters · filed 2020-03-11 | $4.34M derived: sum of 3 quarters · filed 2020-03-11 | $4.83M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.47M derived: sum of 2 quarters · filed 2019-11-07 | $3.96M 10-Q · filed 2019-11-07 | $5.57M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.67M 10-Q · filed 2019-08-09 | $4.28M derived: sum of 3 quarters · filed 2019-08-09 | $5.04M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $489.00K 10-Q · filed 2019-05-09 | $2.10M derived: sum of 2 quarters · filed 2019-05-09 | $2.86M derived: sum of 3 quarters · filed 2019-05-09 | $3.28M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $2.37M derived: sum of 2 quarters · filed 2019-03-08 | $2.79M derived: sum of 3 quarters · filed 2019-03-08 | $5.50M 10-K · filed 2019-03-08 |
| 2017-09-30 | $755.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.18M derived: sum of 2 quarters · filed 2018-11-08 | $3.89M 10-Q · filed 2018-11-08 | $6.99M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $3.13M 10-Q · filed 2018-08-08 | $6.23M derived: sum of 3 quarters · filed 2019-03-08 | $9.57M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $2.71M 10-Q · filed 2018-05-10 | $5.81M derived: sum of 2 quarters · filed 2019-03-08 | $9.15M derived: sum of 3 quarters · filed 2019-03-08 | $12.43M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $6.44M derived: sum of 2 quarters · filed 2019-03-08 | $9.72M derived: sum of 3 quarters · filed 2019-03-08 | $11.03M 10-K · filed 2019-03-08 |
| 2016-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.62M derived: sum of 2 quarters · filed 2017-11-09 | $7.93M 10-Q · filed 2017-11-09 | $12.92M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.59M 10-Q · filed 2017-08-09 | $9.59M derived: sum of 3 quarters · filed 2018-03-16 | $14.05M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $1.31M 10-Q · filed 2017-05-10 | $6.31M derived: sum of 2 quarters · filed 2018-03-16 | $10.77M derived: sum of 3 quarters · filed 2018-03-16 | $17.82M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $9.46M derived: sum of 2 quarters · filed 2018-03-16 | $16.51M derived: sum of 3 quarters · filed 2018-03-16 | $22.53M 10-K · filed 2018-03-16 |
| 2015-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $11.51M derived: sum of 2 quarters · filed 2016-11-09 | $17.53M 10-Q · filed 2016-11-09 | $23.84M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $7.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $13.07M 10-Q · filed 2016-08-09 | $19.38M derived: sum of 3 quarters · filed 2017-03-14 | $27.79M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $6.02M 10-Q · filed 2016-05-10 | $12.33M derived: sum of 2 quarters · filed 2017-03-14 | $20.74M derived: sum of 3 quarters · filed 2017-03-14 | $27.69M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $14.72M derived: sum of 2 quarters · filed 2017-03-14 | $21.67M derived: sum of 3 quarters · filed 2017-03-14 | $26.29M 10-K · filed 2017-03-14 |
| 2014-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $15.36M derived: sum of 2 quarters · filed 2015-11-06 | $19.97M 10-Q · filed 2015-11-06 | $23.95M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $11.57M 10-Q · filed 2015-08-10 | $15.55M derived: sum of 3 quarters · filed 2016-03-14 | $17.81M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $4.61M 10-Q · filed 2015-05-11 | $8.59M derived: sum of 2 quarters · filed 2016-03-14 | $10.85M derived: sum of 3 quarters · filed 2016-03-14 | $12.02M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $6.24M derived: sum of 2 quarters · filed 2016-03-14 | $7.41M derived: sum of 3 quarters · filed 2016-03-14 | $8.57M 10-K · filed 2016-03-14 |
| 2013-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.42M derived: sum of 2 quarters · filed 2014-11-06 | $4.59M 10-Q · filed 2014-11-06 | $5.60M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.33M 10-Q · filed 2014-08-07 | $3.34M derived: sum of 3 quarters · filed 2015-03-13 | $6.40M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $1.17M 10-Q · filed 2014-05-08 | $2.18M derived: sum of 2 quarters · filed 2015-03-13 | $5.23M derived: sum of 3 quarters · filed 2015-03-13 | $6.88M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $4.07M derived: sum of 2 quarters · filed 2015-03-13 | $5.71M derived: sum of 3 quarters · filed 2015-03-13 | $6.63M 10-K · filed 2015-03-13 |
| 2012-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $4.70M derived: sum of 2 quarters · filed 2013-11-08 | $5.62M 10-Q · filed 2013-11-08 | $6.92M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.56M 10-Q · filed 2013-08-09 | $3.86M derived: sum of 3 quarters · filed 2014-03-17 | $4.29M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $917.00K 10-Q · filed 2013-05-09 | $2.22M derived: sum of 2 quarters · filed 2014-03-17 | $2.64M derived: sum of 3 quarters · filed 2014-03-17 | $3.13M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.73M derived: sum of 2 quarters · filed 2014-03-17 | $2.21M derived: sum of 3 quarters · filed 2014-03-17 | $2.42M 10-K · filed 2014-03-17 |
| 2011-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $908.00K derived: sum of 2 quarters · filed 2012-11-06 | $1.12M 10-Q · filed 2012-11-06 | $1.59M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $694.00K 10-Q · filed 2012-08-03 | $1.17M derived: sum of 3 quarters · filed 2013-03-07 | $2.00M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $209.00K 10-Q · filed 2012-05-08 | $686.00K derived: sum of 2 quarters · filed 2013-03-07 | $1.52M derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $1.31M derived: sum of 2 quarters · filed 2013-03-07 | $2.60M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $832.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $2.12M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $1.29M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $3.21M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |